首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin
【24h】

Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin

机译:Fenfluramine诱导的PVAT依赖性收缩取决于去甲肾上腺素而不是血清素

获取原文
获取原文并翻译 | 示例
           

摘要

Perivascular adipose tissue (PVAT) modulates vascular tone and altered PVAT function is observed in vascular diseases such as hypertension and atherosclerosis. We discovered that the PVAT surrounding rat thoracic aorta (RA) and the superior mesenteric artery (SMA) contain significant amounts of 5-hydroxytryptamine (5-HT). We hypothesized that the 5-HT contained within the PVAT is functional and vasoactive. Isolated tissue baths were used for isometric contractility studies and high performance liquid chromatography was used to quantitatively measure amines in the PVAT and release studies. The 5-HT releaser fenfluramine (10 nM-100 mu M) was tested for its ability to contract arteries with and without PVAT. Contraction was reported as a percentage of the initial contraction to 10 mu M phenylephrine. The RA with PVAT contracted to fenfluramine to a greater maximum (98 +/- 10%) than RA without PVAT (24 +/- 4%), while no difference in contraction of SMA to maximum fenfluramine with (78 +/- 2%) and without (75 +/- 6%) PVAT was observed. Contradicting our hypothesis, the maximum contraction of RA with PVAT to fenfluramine was diminished by the alpha-1 adrenoreceptor antagonist prazosin (100 nM; vehicle: 71 +/- 4%, prazosin: 24 +/- 2%) and the norepinephrine transporter (NET) inhibitor nisoxetine (1 mu M; vehicle: 71 +/- 4%, nisoxetine: 25 +/- 4%) but not the 5-HT2A/2C receptor antagonist ketanserin (10 nM) or serotonin specific reuptake inhibitor fluoxetine (10 mu M). To test if fenfluramine caused release of 5-HT or NE from PVAT, PVAT from RA was incubated with vehicle or fenfluramine (10 mu M-10 mM), and amines released into the incubating buffer were quantified. A pronounced concentration-dependent NE-release (more than 5-HT) was observed. Collectively, this research illustrates the pharmacology of fenfluramine to primarily stimulate NE release (better than 5-HT) in a NET-dependent manner, leading to vasoconstriction. This adds additional support to PVAT as being an important reservoir of amines.
机译:血管脂肪脂肪组织(PVAT)调节血管间调和改变的PVAT功能在高血压和动脉粥样硬化等血管疾病中观察到。我们发现围绕大鼠胸主动脉(Ra)和上肠系膜动脉(SMA)的PVAT含有大量的5-羟基 - 羟胺(5-HT)。我们假设PVAT中包含的5-HT是功能性和血管活性的。隔离的组织浴被用于等距收缩性研究,高效液相色谱法用于定量测量PVAT和释放研究中的胺。测试5-HT释放器芬氟胺(10nm-100 mu m)的测试能力与含有PVAT的合同动脉。报告的收缩作为初始收缩至10μm吩苯杂环的百分比。具有PVAT的PVAT的RA比没有PVAT的最大(98 +/- 10%),而没有PVAT(24 +/- 4%),而SMA的收缩没有差异(78 +/- 2%) )没有观察到(75 +/- 6%)PVAT。与我们的假设相矛盾,用PVAT与Fenfluramine的Ra的最大收缩由Alpha-1肾上腺素拮抗剂(100nm;载体:71 +/- 4%,普拉佐宁:24 +/- 2%)和去甲肾上腺素转运蛋白(净抑制剂硝基苯甲酸(1 mu m;车辆:71 +/- 4%,硝基甲酰胺:25 +/- 4%)但不是5-ht2a / 2c受体拮抗剂酮柳素(10nm)或血清素特异性再摄取抑制剂氟西汀(10 mu m)。为了测试FENFLURAMINE从PVAT引起的5-HT或NE释放,从RA与载体或芬氟胺(10μm-10mm)一起孵育PVAT,并定量释放到孵育缓冲液中的胺。观察到明显的浓度依赖性NE释放(超过5-HT)。统称,该研究说明了芬氟胺的药理学以依赖于血管的方式刺激NE释放(优于5-HT),导致血管收缩。这增加了PVAT的额外支持,作为胺的重要水库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号